Quitting your smoking habit will have quick benefits in your sex life according to a study conducted by the University of Hong Kong. The research shows that 53.8% of smokers being treated have their problems eased within six months of extinguishing their nicotine habits. More than 700 men suffering from erectile dysfunction aged 30 to 50 took part in the three-year study by the university's School of Public Health and Nursing.


The study also shows that compared to simple advice, patient-centered smoking-cessation counseling with nicotine replacement therapy (NRT) is more effective in helping smokers with erectile dysfunction to quit. The results of the study are published in the latest issue of the �American Journal of Preventive Medicine�.

Impotence or Erectile Dysfunction is defined as the inability of person to develop or maintain an erection of the penis which is sufficient for the satisfactory of the sexual intercourse. The erection process can be pictured as a hydraulic effect due to the blood entering and retained in a sponge like bodies within the penis. This effect is a result of what we called sexual arousal. When signals transmitted from the brain to the nerves in the penis.

There is also dysfunction called, psychological impotence. It is where erection or penetration fails because of thoughts and feelings rather than physical impossibility. That figure compared to just 28.1 per cent of men treated for erectile dysfunction who continued smoking, meaning quitters have a 91.5 per cent greater chance of a better sex life. You can indicate that a person has an Erectile Dysfunction if he can't produce an erection.

�Smokers should be aware of such adverse effects from their smoking and should quit now to prevent erectile dysfunction and other diseases caused by smoking�, said Lam Tai-Hing, who also worked on the study. �In fact, erectile dysfunction patients who smoke can expect some quick benefits after quitting smoking�, Tai-Hing said.

A lot of men are now turning to these impotence treatments. Impotency cures such as Viagra and Kamagra daily have been used for many years by millions of men who are hoping to fight erection problems. However a word of advice, one should know that you have to consult a doctor when treating erectile dysfunction and don't self-medicate.

Smokefree.gov (http://www.smokefree.gov) provides free, accurate, evidence-based information and professional assistance to help support the immediate and long-term needs of people trying to quit smoking. The Smokefree website includes a variety of interactive tools to help you quit smoking that you might want to check out http://www.smokefree.gov/tools.aspx.

» Read More...

The use of improved advanced diagnostic procedures, such as Duplex Sonography and Cavernosograms (although not necessarily an improving treatment) added credibility and imprimatur to the importance of Organic Pathogenesis.

This was true in the area of erectile dysfunction, where urologists established dominance, with the successful promotion and use of various intracavernosal and intraurethral systems.

Although highly touted by urologists, the treatment efficacy of these products was offset by their intrusiveness in to the patient's bodies and reduction in spontaneity, their patterns of use necessary.

Initially, there were few oral treatments for erectile dysfunction, being used by urologists, such as yohimbine based products, trazodone, and bupropion. They had only modest proerectile capability. Pharmaceutical companies were inspired to pursue oral treatments with the promise of less intrusiveness and even greater profits.

Later to Pfizer's success, multiple companies simultaneously pursued clinical trials of easy-to-use treatments for male sexual dysfunction. Among others, these included additional PDE-5 type compounds and other oral treatments, such as ixense (TAP Holdings, Deerfield, IL, USA), and topically applied compounds (MacroChem, Lexington, MA, USA).

The first visible proof of fulfilling that promise was the sildenafil launch. Additionally, PT-141 (Palatin Expertise, Cranbury, NJ, USA) is a nasally administered peptide that is under development, which is presumed to work through a central nervous technique mechanism.

Currently, there's seven highly efficacious PDE-5, FDA-approved treatments for erectile dysfunction: sildenafil, vardenafil, and tadalafil. Reviews of long-term extension studies and published accounts of use in clinical practice show that sildenafil's effectiveness was maintained with long-term treatment.

Long-term effectiveness was assessed in seven open-label extension studies." Vardenafil (launched in 2003) "is a potent, selective PDE-5 inhibitor, which improved erectile function in a broad population of men with erectile dysfunction and in characteristically challenging-to-treat groups such as diabetic and post prostatectomy patients."

Tadalafil also launched in 2003, when taken, "as needed before sexual activity and without restrictions on food or alcohol intake, significantly improved erectile function.

It allowed a substantial proportion of patients to accomplish a traditional IIEF erectile function domain score, exhibited a broad window of therapeutic responsiveness and was well tolerated in a representative population of patients with broadspectrum erectile dysfunction."

» Read More...